Men with CADASIL in a nationwide South Korean registry had ischaemic stroke far more often than women, 70.9 per cent against 44.4 per cent, and had their first event at a younger age (median 53 years against 59, log-rank p less than 0.001), according to a retrospective observational study published in Neurology Genetics on 9 March 2026. Investigators screened 577 patients across 26 centres and analysed 368 (179 men, 189 women) with pathogenic NOTCH3 variants; mean age at data collection was 61.7 years (SD 11.9). On MRI, rated by a single neuroradiologist using the CADA-MRIT scheme, male sex was independently associated with greater lacune burden (odds ratio 3.03, 95 per cent CI 1.70 to 5.38). Women showed a tendency to higher white matter hyperintensity volume, which did not survive adjustment for age, variant position and vascular risk factors. Women reported recurrent headache more often (35.4 per cent against 16.9 per cent), and dementia was recorded in 19.6 per cent of women and 13.4 per cent of men, a difference that was not statistically significant (p = 0.117).
The bleeding question, which is what makes sex differences in Asian CADASIL cohorts clinically pointed, did not resolve into a sex split. Intracerebral haemorrhage was recorded in 9.5 per cent of the whole group, roughly 35 people, and the authors' earlier preprint of the same cohort reported no significant sex difference in its onset (hazard ratio 2.04, 95 per cent CI 0.80 to 5.18, p = 0.136), a confidence interval wide enough to include a halving or a fivefold increase in risk. Cerebral microbleeds were rated alongside lacunes, white matter change and atrophy, but were not among the markers reported as independently associated with sex. The imaging signal that held up after adjustment was lacunes in men.
The context matters for readers outside Korea. CADASIL is the most common inherited small vessel disease, caused by NOTCH3 variants, and most published series are European. Asian cohorts differ: an international validation of the CADA-MRIT imaging tool, published in Neurology in October 2023 and covering 671 patients from France, Germany and Taiwan, found microbleeds in 83 per cent of the Asian cohort against 35 per cent of European patients. The Korean registry also reflects a distinct genetic profile, with 36 distinct pathogenic variants and R544C in 40.8 per cent of patients and R75P in 17.9 per cent.
The counterpoint is the study design. This is a retrospective chart and imaging review of people who reached a genetics service and were tested, not a population sample, so who appears in the registry is shaped by referral patterns; headache in women, for instance, may be reported and recorded differently from stroke in men. Differences in vascular risk factor profiles between the sexes were adjusted for in the models but cannot be removed from an observational dataset. The authors describe their results as showing sex is worth treating as a biological variable in CADASIL prognosis and management, not as a rule for treatment.